ATE64092T1 - Topische zusammensetzung. - Google Patents
Topische zusammensetzung.Info
- Publication number
- ATE64092T1 ATE64092T1 AT85107569T AT85107569T ATE64092T1 AT E64092 T1 ATE64092 T1 AT E64092T1 AT 85107569 T AT85107569 T AT 85107569T AT 85107569 T AT85107569 T AT 85107569T AT E64092 T1 ATE64092 T1 AT E64092T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- group
- inflammatory activity
- possess
- topical composition
- Prior art date
Links
- 230000000699 topical effect Effects 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848416638A GB8416638D0 (en) | 1984-06-29 | 1984-06-29 | Topical treatment and composition |
| EP85107569A EP0167062B1 (de) | 1984-06-29 | 1985-06-19 | Topische Zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE64092T1 true ATE64092T1 (de) | 1991-06-15 |
Family
ID=10563185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85107569T ATE64092T1 (de) | 1984-06-29 | 1985-06-19 | Topische zusammensetzung. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4661524A (de) |
| EP (1) | EP0167062B1 (de) |
| JP (1) | JPH0714869B2 (de) |
| AT (1) | ATE64092T1 (de) |
| AU (1) | AU584340B2 (de) |
| CA (1) | CA1246458A (de) |
| DE (1) | DE3583069D1 (de) |
| DK (1) | DK159757C (de) |
| GB (1) | GB8416638D0 (de) |
| IE (1) | IE58101B1 (de) |
| NZ (1) | NZ212577A (de) |
| ZA (1) | ZA854857B (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9019413D0 (en) * | 1990-09-05 | 1990-10-17 | Beecham Group Plc | Topical treatment and composition |
| GB9024798D0 (en) * | 1990-11-14 | 1991-01-02 | Beecham Group Plc | Naphthyl derivative for treatment method |
| GB9108128D0 (en) * | 1991-04-15 | 1991-06-05 | Zambeletti Spa L | Novel formulation |
| US5214035A (en) * | 1992-04-16 | 1993-05-25 | Hoechst-Roussel Agri-Vet Company | Thixotropic formulations |
| US5464988A (en) * | 1994-11-23 | 1995-11-07 | The United States Of America As Represented By The Department Of Energy | Tritium waste package |
| US5883103A (en) * | 1995-06-07 | 1999-03-16 | Shire Laboratories Inc. | Oral acyclovir delivery |
| US6046244A (en) * | 1997-11-05 | 2000-04-04 | Nexmed Holdings, Inc. | Topical compositions for prostaglandin E1 delivery |
| US6414028B1 (en) * | 1997-11-05 | 2002-07-02 | Nexmed Holdings, Inc. | Topical compositions containing prostaglandin E1 |
| TWI262791B (en) | 1999-10-27 | 2006-10-01 | Nobex Corp | 6-methoxy-2-naphthylacetic acid prodrugs |
| US6552078B2 (en) | 1999-10-27 | 2003-04-22 | Nobex Corp | 6-methoxy-2-naphthylacetic acid prodrugs |
| US6436990B1 (en) | 1999-10-27 | 2002-08-20 | Nobex Corporation | 6-methoxy-2-naphthylacetic acid prodrugs |
| US6967023B1 (en) * | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US20060140984A1 (en) | 2002-10-25 | 2006-06-29 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| WO2005076697A2 (en) * | 2004-02-04 | 2005-08-25 | Foamix Ltd. | Cosmetic and pharmaceutical foam with solid matter |
| JP2005310310A (ja) * | 2004-04-23 | 2005-11-04 | Sanyo Electric Co Ltd | トラッキングバランス調整装置 |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| WO2009090558A2 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| AU2010302350B2 (en) | 2009-10-02 | 2015-06-18 | Journey Medical Corporation | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1474377A (en) * | 1973-09-11 | 1977-05-25 | Beecham Group Ltd | Naphthalene derivatives |
| CA1049039A (en) * | 1974-12-31 | 1979-02-20 | Beecham Group Limited | Aromatic ketones |
| US4126681A (en) * | 1975-12-08 | 1978-11-21 | The Procter & Gamble Company | Topical composition containing acetyl salicylic acid |
| DE2860631D1 (en) * | 1978-01-07 | 1981-05-07 | Beecham Group Plc | Process for the preparation of 4-(6-methoxy-2-naphthyl)butan-2-one and 2-acetyl-3-(6-methoxy-2-naphthyl) propenoic acid esters |
| US4221741A (en) * | 1978-01-27 | 1980-09-09 | Beecham Group Limited | Preparation of 4(6'-methoxy-2'-naphthyl)butan-2-one |
| CA1142965A (en) * | 1979-06-08 | 1983-03-15 | Alexander C. Goudie | Substituted decalins, their preparation and use |
| JPS57171912A (en) * | 1981-04-14 | 1982-10-22 | Sumitomo Chem Co Ltd | Cream |
| JPS5883622A (ja) * | 1981-11-10 | 1983-05-19 | Hisamitsu Pharmaceut Co Inc | 消炎鎮痛ゲル状クリーム剤 |
| JPS5921654A (ja) * | 1982-06-30 | 1984-02-03 | ル−イ・ジエイ・ユ | フエニルアルフア−アシルオキシアセトアミド誘導体及びその組成物 |
-
1984
- 1984-06-29 GB GB848416638A patent/GB8416638D0/en active Pending
-
1985
- 1985-06-19 EP EP85107569A patent/EP0167062B1/de not_active Expired - Lifetime
- 1985-06-19 DE DE8585107569T patent/DE3583069D1/de not_active Expired - Fee Related
- 1985-06-19 AT AT85107569T patent/ATE64092T1/de not_active IP Right Cessation
- 1985-06-25 AU AU44132/85A patent/AU584340B2/en not_active Ceased
- 1985-06-27 DK DK291685A patent/DK159757C/da not_active IP Right Cessation
- 1985-06-27 NZ NZ212577A patent/NZ212577A/en unknown
- 1985-06-27 IE IE161585A patent/IE58101B1/en not_active IP Right Cessation
- 1985-06-27 ZA ZA854857A patent/ZA854857B/xx unknown
- 1985-06-27 CA CA000485589A patent/CA1246458A/en not_active Expired
- 1985-06-28 JP JP60140694A patent/JPH0714869B2/ja not_active Expired - Fee Related
- 1985-12-27 US US06/814,205 patent/US4661524A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK159757B (da) | 1990-12-03 |
| CA1246458A (en) | 1988-12-13 |
| DK291685A (da) | 1985-12-30 |
| US4661524A (en) | 1987-04-28 |
| AU584340B2 (en) | 1989-05-25 |
| NZ212577A (en) | 1988-02-12 |
| JPH0714869B2 (ja) | 1995-02-22 |
| DK159757C (da) | 1991-04-22 |
| AU4413285A (en) | 1986-02-20 |
| JPS6118718A (ja) | 1986-01-27 |
| ZA854857B (en) | 1986-04-30 |
| EP0167062A2 (de) | 1986-01-08 |
| GB8416638D0 (en) | 1984-08-01 |
| DE3583069D1 (de) | 1991-07-11 |
| EP0167062A3 (en) | 1988-03-30 |
| DK291685D0 (da) | 1985-06-27 |
| IE851615L (en) | 1985-12-29 |
| IE58101B1 (en) | 1993-06-30 |
| EP0167062B1 (de) | 1991-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE64092T1 (de) | Topische zusammensetzung. | |
| EP0219876A3 (en) | Antihypertensive agents comprising 2-alkynyladenosines as active ingredients | |
| ATE23716T1 (de) | 5,6,7-trinor-4,8-inter-m-phenylen-prostaglandin i2-derivate. | |
| ATE37179T1 (de) | Dihydropyridazinone. | |
| NO153455C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte imidazolderivater. | |
| AU4039285A (en) | 1,5-benzothiazepine derivatives | |
| AU552908B2 (en) | 4 n-phenyl benzyl-aminomethyl-imidazole | |
| FI860674A0 (fi) | Alken-, alkyn- eller cykloalkylenderivat. | |
| AU577772B2 (en) | Di-acyloxy naphthalenes & di-hydroxy intermediates as anti-psoriatic agents | |
| NO163957C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser. | |
| ATE50773T1 (de) | Alkylresorcinolphosphite. | |
| GB1479297A (en) | 4-substituted butan-2-ones but-3-en-2-ones butan-2-ols and but-3-en-2-ols and pharmaceutical compositions containing them | |
| ATE40127T1 (de) | 1,5-benzothiazepinderivate, verfahren zu ihrer herstellung und arzneimittel. | |
| IE780126L (en) | Thiazoloisoquinoline derivatives | |
| AU586477B2 (en) | Hexenoic acids | |
| ZA825576B (en) | Benzodioxane-imidazoline compounds as antihypertensives | |
| ES8301931A1 (es) | Un procedimiento para la preparacion de nuevos imidazoles. | |
| MY102090A (en) | Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom | |
| ES8700859A1 (es) | Un procedimiento para la preparacion de nuevos derivados pe-nem | |
| GB1513280A (en) | Therapeutic pyrazole derivatives | |
| ZA811585B (en) | Anti-inflammatory compositions | |
| ATE63537T1 (de) | Carbacyclin-derivate. | |
| MY104099A (en) | Anti inflammatory carbinoloimidazoles. | |
| GB1307255A (en) | Substituted basic benzhydryl ethers | |
| ES8304083A2 (es) | Mejoras introducidas en el objeto de la patente principal n.495.932 por:un procedimiento para la preparacion de deriva- dos de piridina o de pirimidina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |